4.5 Letter

Carbonic anhydrase-related protein VIII antibodies and paraneoplastic cerebellar degeneration

Journal

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Volume 40, Issue 5, Pages 650-653

Publisher

WILEY-BLACKWELL
DOI: 10.1111/nan.12118

Keywords

-

Funding

  1. NCI NIH HHS [R01CA89054, R01 CA089054] Funding Source: Medline
  2. NINDS NIH HHS [R01NS077851, R01 NS077851] Funding Source: Medline
  3. ICREA Funding Source: Custom

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Clinical Neurology

Comment on Paraneoplastic encephalomyelitis revealing burned-out seminoma: confirmed case of anti-Kelch-like protein-11 encephalomyelitis

Sofia Maldonado Slootjes, Jon Landa, Lidia Sabater, Vincent van Pesch

ACTA NEUROLOGICA BELGICA (2022)

Review Genetics & Heredity

CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative

Juan Luque, Ingrid Mendes, Beatriz Gomez, Beatriz Morte, Miguel Lopez de Heredia, Enrique Herreras, Virginia Corrochano, Juan Bueren, Pia Gallano, Rafael Artuch, Cristina Fillat, Luis A. Perez-Jurado, Lluis Montoliu, Angel Carracedo, Jose M. Millan, Susan M. Webb, Francesc Palau, Pablo Lapunzina

Summary: CIBERER, a thematic area of CIBER, focuses on rare disease research. It aims to facilitate collaboration between biomedical and clinical research groups and provide new tools for the diagnosis and therapy of low-prevalence diseases.

CLINICAL GENETICS (2022)

Editorial Material Clinical Neurology

MOGAD comes of age with new criteria

Francesc Graus, Josep Dalmau

LANCET NEUROLOGY (2023)

Review Clinical Neurology

Anti-kelchlike protein 11 antibody-associated encephalitis: Two case reports and review of the literature

Alejandro Leon Betancourt, Anina Schwarzwald, Alban Millonig, Michael Oberholzer, Lidia Sabater, Helly Hammer, Nicole Kamber, Lara Diem, Andrew Chan, Robert Hoepner, Anke Salmen, Christoph Friedli

Summary: KLHL11-IgG encephalitis is a rare autoimmune disease associated with testicular germ cell tumors. Early diagnosis and treatment are crucial, and further research is needed to address therapeutic management.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Editorial Material Clinical Neurology

Can Neurofilament Light Chain Be Utilized as a Biomarker of Disease Severity, Activity, and Outcomes in Anti-NMDA Receptor Encephalitis?

Amy Kunchok, Josep Dalmau

Summary: Anti-NMDA receptor encephalitis is characterized by behavioral, cognitive, and psychiatric alterations, along with seizures, abnormal movements, dysautonomia, or decreased consciousness. These symptoms develop sequentially over several weeks in association with NMDAR-IgG in cerebrospinal fluid. After the initial presentation, persistent symptoms may last for weeks or months and often require ICU care, followed by a slow recovery. Changes in CSF antibody titers may correlate with relapse, but serum titers are unreliable biomarkers of disease activity.

NEUROLOGY (2023)

Article Clinical Neurology

Searching for Neuronal Antibodies in Psychiatric Diseases

Mar Guasp, Josep Dalmau

Summary: In recent years, there have been numerous reports on individual symptoms of autoimmune encephalitis (AE) in neurology and psychiatry journals. However, the presence of antibodies in psychiatric diseases has not defined any specific disorder or affected the diagnosis and treatment of patients. These studies often lack rigorous investigations and fail to address the clinical significance and limitations of antibody testing techniques. Clinical judgment is emphasized as important in interpreting antibody findings.

NEUROLOGY (2023)

Article Immunology

Patients' IgLON5 autoantibodies interfere with IgLON5-protein interactions

Jon Landa, Ana Beatriz Serafim, Carles Gaig, Albert Saiz, Inga Koneczny, Romana Hoftberger, Joan Santamaria, Josep Dalmau, Francesc Graus, Lidia Sabater

Summary: This study explores the interactome of IgLON5 and demonstrates that IgLON5 antibodies can interfere with its protein interactions. The findings reveal a potentially novel pathogenic mechanism of IgLON5 antibodies in blocking its interactions with binding partners, extending our knowledge about the physiological role of IgLON5 and contributing to the understanding of the pathological mechanisms of anti-IgLON5 disease.

FRONTIERS IN IMMUNOLOGY (2023)

Article Immunology

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies

Cristina Arnaldos-Perez, Andreu Vilaseca, Laura Naranjo, Lidia Sabater, Josep Dalmau, Raquel Ruiz-Garcia, Francesc Graus

FRONTIERS IN IMMUNOLOGY (2023)

Article Clinical Neurology

The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis

Susanna Asseyer, Nasrin Asgari, Jeffrey Bennett, Omer Bialer, Yolanda Blanco, Francesca Bosello., Anna Camos-Carreras., Edgar Carnero Contentti., Sara Carta, John Chen, Claudia Chien, Mashina Chomba, Russell C. Dale, Josep Dalmau, Kristina Feldmann, Eoin P. Flanagan, Caroline Froment Tilikete, Carolina Garcia-Alfonso, Joachim Havla, Mark Hellmann, Ho Jin Kim, Philipp Klyscz, Frank Konietschke, Chiara La Morgia, Marco Lana-Peixoto, Maria Isabel Leite, Netta Levin, Michael Levy, Sara Llufriu, Pablo Lopez, Itay Lotan, Alessandra Lugaresi, Romain Marignier, Sara Mariotto, Susan P. Mollan, Cassandra Ocampo, Frederike Cosima Oertel, Maja Olszewska, Jacqueline Palace, Lekha Pandit, Jose Luis Peralta Uribe, Sean Pittock, Sudarshini Ramanathan, Natthapon Rattanathamsakul, Albert Saiz, Sara Samadzadeh, Bernardo Sanchez-Dalmau, Deanna Saylor, Michael Scheel, Tanja Schmitz-Huebsch, Jemal Shifa, Sasitorn Siritho, Pia S. Sperber, Prem S. Subramanian, Alon Tiosano, Adi Vaknin-Dembinsky, Alvaro Jose Mejia Vergara, Adi Wilf-Yarkoni, Luis Alfonso Zarco, Hanna G. Zimmermann, Friedemann Paul, Hadas Stiebel-Kalish

Summary: This is a global study aimed at investigating the effect of early high-dose corticosteroid treatment on optic neuritis. The study will collect various data to evaluate treatment strategies and the accuracy of diagnostic criteria.

FRONTIERS IN NEUROLOGY (2023)

Article Clinical Neurology

Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies

Thais Armangue, Gemma Olive-Cirera, Eugenia Martinez-Hernandez, Maria Rodes, Vicente Peris-Sempere, Mar Guasp, Raquel Ruiz, Eduard Palou, Azucena Gonzalez, Ma angeles Marcos, Maria Elena Erro, Luis Bataller, Inigo Corral-Corral, Jesus Planaguma, Eva Caballero, Alexandru Vlagea, Jie Chen, Paul Bastard, Marie Materna, Astrid Marchal, Laurent Abel, Aurelie Cobat, Laia Alsina, Claudia Fortuny, Albert Saiz, Emmanuel Mignot, Adeline Vanderver, Jean-Laurent Casanova, Shen-Ying Zhang, Josep Dalmau, Spanish HSE Study Grp

Summary: Patients with herpes simplex virus encephalitis often develop neuronal autoantibody-associated encephalitis post-infection. This study found that risk factors for post-HSE AE may include genetic variants, HLA haplotypes, and the blood innate immune response against HSV. These findings have potential clinical applications for the diagnosis and monitoring of HSE complications.

BRAIN (2023)

Correction Immunology

Patients' IgLON5 autoantibodies interfere with IgLON5-protein interactions (vol 14,1151574, 2023)

Jon Landa, Ana Beatriz Serafim, Carles Gaig, Albert Saiz, Inga Koneczny, Romana Hoftberger, Joan Santamaria, Josep Dalmau, Francesc Graus, Lidia Sabater

FRONTIERS IN IMMUNOLOGY (2023)

Article Clinical Neurology

Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease

Josep Dalmau, Francesc Graus

Summary: Increased awareness of autoimmune encephalitis has led to misdiagnoses and inappropriate use of diagnostic criteria for antibody-negative disease. Misdiagnoses occur due to non-adherence to clinical requirements, inadequate assessment, and limited use of assays. Clinicians should adhere to published criteria and substantiate absence of neural antibodies. Accurate diagnosis will help assess treatment response and outcomes.

LANCET NEUROLOGY (2023)

No Data Available